Investigations with the aim of obtaining a mass for pressing medicated chewing gums "Lysodent C"

Journal Title: ScienceRise: Pharmaceutical Science - Year 2019, Vol 0, Issue 3

Abstract

<p>The design of high quality compressed medicated chewing gum "Lysodent C" with lysozyme hydrochloride and ascorbic acid as active pharmaceutical ingredients and the composition Health in Gum<sup>®</sup> PWD-01 as a chewable gum base involves obtaining a homogeneous mass for pressing. In order to prevent the segregation of the mass for pressing due to its polydispersity, it was necessary to carry out a preliminary granulation of the substance of lysozyme hydrochloride, which is characterized by fine dispersion, hygroscopicity and insufficient pharmacotechnological properties for direct compression method.</p><p><strong>Aim of the work </strong>– to carry out physicochemical and pharmacotechnological studies in order to obtain a homogeneous mass for pressing medicated chewing gums "Lysodent C".</p><p><strong>Materials and methods. </strong>The objects of study are granulate of lysozyme hydrochloride (Bouwhuis Enthoven, the Netherlands) with an intensive sweetener sucralose (Solo Sucralose-Non Micronised NF, VB Medicare PVT. LTD., India) and a flavoring agent (Nat Apple Flavor Wonf, Kerry Inc., Malaysia), and also a mass for pressing, obtained by mixing the granulate, the composition Health in Gum<sup>®</sup> PWD-01 (Cafosa, Spain) and ascorbic acid (Foodchem, China). As a granulating liquid ethanol 96 % was used. During the experiment, physicochemical (moisture absorption capacity), pharmacotechnological (optical microscopy, flowability, bulk density and tapped density, determination of particle size by analytical sieving) and statistical studies in accordance with the requirements of SPhU 2.0 were used.</p><p><strong>Results</strong><strong>. </strong>Crystallographic analysis revealed similarity in size and shape of the obtained lysozyme hydrochloride granulates with the granules of Health in Gum<sup>®</sup> PWD-01, which was also confirmed by the study of the fractional composition – particles with a size of 1.0 &gt; n ≥ 0.7 are their main fraction. In addition, the conversion of lysozyme hydrochloride powder to granules improved its pharmacotechnological characteristics. However, granulate, like the pure substance of lysozyme hydrochloride, is hygroscopic, which requires, respectively, a decrease in its moisture absorption capacity. Crystallographic analysis of the mixture obtained by mixing the granulate and Health in Gum® PWD-01 with premixing of ascorbic acid, established its dispersion homogeneity, and the study of its technological characteristics – good flowability, which will ensure high-quality compressed gums. The moisture absorption capacity of the formed mass for pressing did not decrease, but on the contrary increased, due to the presence in the mixture of such hygroscopic components as lysozyme hydrochloride and chewing gum base.</p><p><strong>Conclusions.</strong> It was established that the use of pre-granulation of lysozyme hydrochloride led to the homogeneity of the resulting mass for pressing. However, the hygroscopicity of the mixture requires the introduction of moisture-absorbing agents in its composition or compliance with 40 % of the relative humidity of the environment during the preparation of the drug</p>

Authors and Affiliations

Yuliia Maslii, Olena Ruban, Tetiana Kolisnyk

Keywords

Related Articles

Scientific and practical substantiation of directions of mutual cooperation of higher educational institutions with employers of pharmaceutical sector of health care industry

<p>The aim is to study, summarize and develop the directions of mutual cooperation between higher education institutions with employers of the pharmaceutical sector of the healthcare industry, which will allow making the...

Development of composition and technology of combination drug with neurally mediated action «Memofit»

<p> </p><p><strong>Aim. </strong>The aim of this work is to<strong> </strong>develop composition of combination drug in the form of hard-gelatin capsules «Memofit», determine technological and microbiological parameters...

Investigation of the effects of excipients on technological properties tablets of pyrola rotundifolia extract

<p><strong>Aim of the work. </strong>To study the influence of excipients on the pharmacological and technological properties of round-leaved wintergreen extract tablets.</p><p><strong>Methods. </strong>The subject of th...

The impact of indolinoren on histrotructure of kidney on the glixerroid acute renal failure model

<p>Acute renal failure is one of the most severe conditions of kidney damage. This syndrome is characterized by a sharp decrease in excretory renal function with azotemia and significant violations of water-salt homeosta...

Розробка методики кількісного визначення фенольних сполук у пижма квітках

<p>Великий асортимент сировини дикорослих лікарських рослин використовують для лікування та виготовлення препаратів на їх основі, однією із таких є пижмо звичайне. Обмежена кількість лікарських препаратів пижма на вітчиз...

Download PDF file
  • EP ID EP647846
  • DOI 10.15587/2519-4852.2019.172272
  • Views 178
  • Downloads 0

How To Cite

Yuliia Maslii, Olena Ruban, Tetiana Kolisnyk (2019). Investigations with the aim of obtaining a mass for pressing medicated chewing gums "Lysodent C". ScienceRise: Pharmaceutical Science, 0(3), 11-16. https://www.europub.co.uk/articles/-A-647846